Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging

por D’Hollander A, Mathieu E, Jans H, Vande Velde G, Stakenborg T, Van Dorpe P, Himmelreich U, Lagae L
Publicado 2016